The Chart of the Day belongs to Mirati Therapeutics (MRTX). I found the biomedical stock by using Barchart to sort today’s New 52 Week High list first for the highest Weighted Alpha, then I used the Flipchart feature to review the charts for consistent price appreciation. Since the Trend Spotter signaled a buy on 1/10 the stock gained 60.69%.

Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.

Barchart’s Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the web site when you read this report.

Barchart technical indicators:

  • 100% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 9 new highs and up 25.04% in the last month
  • Relative Strength Index 74.40%
  • Technical support level at 31.40
  • Recently traded at 34.95 with a 50 day moving average of 26.20
  • Fundamental factors:

  • Market Cap $1.00 billion
  • Revenue expected to grow 321.30% next year
  • Earnings estimated to increase 14.40% this year
  • Wall Street analysts issued 6 strong buy and 1 hold recommendation on the stock
  • Print Friendly, PDF & Email